A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of Amlodipine

Completed · Phase 3

Conditions studied: Hypertension

In brief

This study is designed to compare the long-term efficacy and safety of an aliskiren based regimen to an HCTZ based treatment regimen with optional addition of amlodipine in patients with essential hypertension

Key facts

Study ID

NCT00294710

Run by

Novartis

People needed

976

Starts

2005-03-01

Expected to finish

2006-07-01

Last updated by the study team

2011-11-08

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with essential hypertension

You may not qualify if…

• Severe hypertension
• History or evidence of a secondary form of hypertension
• History of myocardial infarction.
• Other protocol-defined inclusion exclusion criteria also apply.

Where it is running

• Novartis — East Hanover, New Jersey, United States
• Study site — Investigative Centers, Germany

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.